H.C. Wainwright Reiterates Buy Rating on Innate Pharma S.A. (IPHA)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St turns lower as crude spikes, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
| (NASDAQ: IPHA) | Delayed: 1.47 -0.05 (3.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.52 | 52 Week High | $ | |||
| Open | $1.51 | 52 Week Low | $ | |||
| Day High | $1.54 | P/E | N/A | |||
| Day Low | $1.47 | EPS | $ | |||
| Volume | 16,272 | |||||
